In the BioHarmony Drug Report Database

"Preview" Icon

Sulfisoxazole

Gantrisin (sulfisoxazole) is a small molecule pharmaceutical. Sulfisoxazole was first approved as Gantrisin on 1982-01-01. It is used to treat bacterial infections, chlamydia infections, mycoses, nocardia infections, and otitis media amongst others in the USA.

 

Trade Name

 

Gantrisin
 

Common Name

 

sulfisoxazole
 

ChEMBL ID

 

CHEMBL453
 

Indication

 

bacterial infections, chlamydia infections, mycoses, nocardia infections, otitis media, protozoan infections, respiratory tract fistula, urinary tract infections
 

Drug Class

 

Image (chem structure or protein)

Sulfisoxazole structure rendering